HBCD included in the Annex XIV list of substances for Authorisation under REACH

With the publication on 18 February 2011 of the amended REACH Annex XIV in the Official Journal, HBCD is officially subject to the Authorisation procedure under REACH, along with five other substances.

The presence of HBCD in Annex XIV does not have any legal impact on the manufacturing and marketing of HBCD containing products until the so called “sunset date” (21 August 2015). After this date, only authorised applications will continue to be allowed.

To read the full statement please download here.